Some women are stopping IVF too early

Submitted by Shelby D Burns Tue 10/29/2013 thinker

Celmatix is a biotechnology company focused on helping physicians guide patients to treatments that maximize their personal reproductive potential. They have announced six research presentations at the annual meeting of the American Society for Reproductive Medicine (ASRM) which further their goal of advising healthcare providers and helping women to achieve pregnancy. One of those studies suggest that some women may be discontinuing with IVF too soon. Better information leads to better decisions Among the studies presented was a new study suggesting that up to 25% of patients may be discontinuing assisted reproductive therapies like in vitro fertilization (IVF) too early while they still have a good chance of having a baby. There are many factors which influence a woman’s decision not to continue with another round of IVF, Celmatix wants to make sure that clinical workers, doctors and patients are informed well about their chances for subsequent pregnancy. If they choose to stop it should be for other reasons (ie financial or emotional) rather than statistical chances of achieving pregnancy. An additional two cycles increase the odds significantly This study looked at over 6,000 patients from Reproductive Medicine Associates of New York. It showed that 68% of women conceived within two cycles. For those who did not conceive in that time frame and chose to discontinue future treatments, the data suggested that more than half (up to 60%) would have become pregnant had they proceeded with an additional two cycles. Statistical, evidence-based information “We are excited to have this opportunity to present our research findings at ASRM, especially our finding that most patients who are initially unsuccessful with fertility treatments still have a significant chance of having a baby,” said Piraye Yurttas Beim, PhD, Founder and chief Executive Officer of Celmatix. “There are so many unanswered questions about why some women struggle with fertility. These questions create difficult decisions for women and their healthcare providers. Our goal is to offer tools and resources that make this process as informed and evidence-based as possible.”

Website | + posts